| Product Code: ETC9625519 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.8 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Taiwan |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Technological advancements in diagnostic tools for non-small cell lung cancer |
4.3 Market Restraints |
4.3.1 High cost associated with advanced diagnostics and treatments |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Taiwan |
5 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 Taiwan Non-Small Cell Lung Cancer Diagnostics Market, By Types |
6.1 Taiwan Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F |
6.1.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F |
6.1.5 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F |
6.1.6 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F |
6.2.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F |
6.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market, By Test |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F |
6.3.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3.5 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F |
6.3.6 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F |
6.3.7 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F |
6.4.5 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries |
7.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries |
8 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
8.1 Average time taken for diagnosis from initial screening |
8.2 Adoption rate of new diagnostic technologies among healthcare providers |
8.3 Number of screening programs conducted in high-risk populations |
9 Taiwan Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
9.1 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
9.4 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Taiwan Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
10.1 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here